β¨ Medicines and Drug Notices
NEW ZEALAND GAZETTE, No. 136
15 NOVEMBER 2012
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Muprin
Active Ingredient: Mupirocin 2%w/w
Dosage Form: Topical ointment
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Hoe Pharmaceuticals Sdn Bhd, Selangor, Malaysia
Product: Your Pharmacy Ibuprofen (General Sale)
Active Ingredient: Ibuprofen 200mg
Dosage Form: Tablet
New Zealand Sponsor: Orion Laboratories (NZ) Limited
Manufacturer: Perrigo Company, Michigan, United States of America
Product: Your Pharmacy Ibuprofen (Pharmacy Only)
Active Ingredient: Ibuprofen 200mg
Dosage Form: Tablet
New Zealand Sponsor: Orion Laboratories (NZ) Limited
Manufacturer: Perrigo Company, Michigan, United States of America
Dated this 8th day of November 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).
go7351
Renewal of Provisional Consent to the Distribution of Medicines
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product: Lioresal Intrathecal
Active Ingredient: Baclofen 0.05mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This renewed consent is valid for two years from 26 November 2012.
Product: Lioresal Intrathecal
Active Ingredient: Baclofen 2mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This renewed consent is valid for two years from 26 November 2012.
Dated this 8th day of November 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).
go7352
Misuse of Drugs Act 1975
Temporary Class Drug Notice
Pursuant to section 4C of the Misuse of Drugs Act 1975, I give notice that the following substances are classified as temporary class drugs:
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare8 November 2012
Medicines Act 1981, New Medicines, Consent, Distribution
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
π₯ Renewal of Provisional Consent to the Distribution of Medicines
π₯ Health & Social Welfare8 November 2012
Medicines Act 1981, Provisional Consent, Renewal, Distribution
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
π₯ Temporary Class Drug Notice
π₯ Health & Social WelfareMisuse of Drugs Act 1975, Temporary Class Drug, Classification
NZ Gazette 2012, No 136